Back to Barclays plc Barclays plc

IRDIRD

8 quarters

Position history for Barclays plcBarclays plc's holdings in Opus Genetics, Inc.

Yes. Barclays holds 13,357 shares of IRD (Opus Genetics), worth $54,897, as of its Q2 2026 13F filing. It increased the position from 1,900 shares in Q1 2026. Barclays has held IRD since Q1 2025, across 6 quarterly 13F filings.

Current Value

$54,897

Current Shares

13,357

Total Value Change

+$52,408

Total Shares Change

+11,457

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
13,357
+603.0%
$54,8970.0%$4.11
23
2026-Q1
Unchanged
1,900
0.0%
$8,6450.0%$4.55
0
2025-Q4
Unchanged
1,900
0.0%
$3,8190.0%$2.01
0
2025-Q3
Unchanged
1,900
0.0%
$3,1350.0%$1.65
0
2025-Q2
Unchanged
1,900
0.0%
$1,7900.0%$0.94
0
2025-Q1
New
1,900
—
$1,8650.0%$0.98
17
2024-Q4
Exited
0
-100.0%
$00.0%$1.19
0
2024-Q3
New
1,900
—
$2,4890.0%$1.31
19

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used